Drug Policy Reform Act of 2021
- Last Action
- 11/1/2022
Actions
- 2022-11-01Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
- 2022-11-01Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.
- 2021-06-21Referred to the Subcommittee on Highways and Transit.
- 2021-06-18Referred to the Subcommittee on Health.
- 2021-06-17Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, Oversight and Reform, Financial Services, Transportation and Infrastructure, House Administration, Armed Services, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-06-17Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, Oversight and Reform, Financial Services, Transportation and Infrastructure, House Administration, Armed Services, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-06-17Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, Oversight and Reform, Financial Services, Transportation and Infrastructure, House Administration, Armed Services, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-06-17Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, Oversight and Reform, Financial Services, Transportation and Infrastructure, House Administration, Armed Services, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-06-17Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, Oversight and Reform, Financial Services, Transportation and Infrastructure, House Administration, Armed Services, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-06-17Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, Oversight and Reform, Financial Services, Transportation and Infrastructure, House Administration, Armed Services, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-06-17Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, Oversight and Reform, Financial Services, Transportation and Infrastructure, House Administration, Armed Services, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-06-17Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, Oversight and Reform, Financial Services, Transportation and Infrastructure, House Administration, Armed Services, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-06-17Introduced in House
- 2021-06-17Introduced in House
CRS Summary
As of 2021-06-17 (00)
Drug Policy Reform Act of 2021 or the DPR Act of 2021
This bill transfers federal regulatory authority over controlled substances, eliminates federal penalties for some drug-related offenses, and removes some collateral consequences for certain criminal convictions. A collateral consequence is a penalty (e.g., a restriction on access to a program or service) imposed on an individual in addition to the penalty associated with the sentence.
Specifically, the bill transfers regulatory authority over controlled substances from the Department of Justice to the Department of Health and Human Services (HHS).
Additionally, the bill directs HHS to establish a commission to determine a benchmark amount of a controlled substance for personal use supply. The bill eliminates federal criminal and civil penalties for simple possession of a controlled substance in an amount equal to or less than the benchmark.
Finally, the bill removes the collateral consequences of certain convictions. For example, the bill
- removes some restrictions on eligibility for federal assistance and benefits for individuals who are convicted of certain drug-related offenses,
- reinstates the right to vote in federal elections for persons convicted of criminal offenses, and
- repeals the requirement for states to revoke or suspend driver's licenses of individuals who are convicted of drug offenses as a condition of receiving a full allocation of certain federal grant funds.
Cosponsors (18)
- Cori Bush (D-MO)
- Gwen Moore (D-WI)
- BENNIE THOMPSON (D-MS)
- Ayanna Pressley (D-MA)
- Alexandria Ocasio-Cortez (D-NY)
- Adriano Espaillat (D-NY)
- BARBARA LEE (D-CA)
- Ilhan Omar (D-MN)
- Jamaal Bowman (D-NY)
- Rashida Tlaib (D-MI)
- DIANA DEGETTE (D-CO)
- J. Correa (D-CA)
- ELEANOR NORTON (D-DC)
- Jesus Garcia (D-IL)
- EARL BLUMENAUER (D-OR)
- Mondaire Jones (D-NY)
- JAMES MCGOVERN (D-MA)
- JANICE SCHAKOWSKY (D-IL)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.